Vitreous loss is a well known complication of cataract surgery. Following vitreous loss there is an increased risk of retinal detachment, expulsive haemorrhage, cystoid macular oedema, corneal decompensation, and secondary glaucoma.' The visual outcome in these patients is compromised.23 After vitreous loss occurs it is common practice to do a partial anterior vitrectomy and then place an anterior chamber lens (AC-IOL). Reports on the effect of placing an AC-IOL after vitreous loss have concluded that in experienced hands it is a safe procedure. ' However, these reports do show that patients who receive an AC-IOL after vitreous loss do significantly less well than those patients who receive a posterior chamber intraocular lens (PC-IOL) after straightforward extracapsular cataract surgery. The contribution of the AC-IOL to this diminished success is unclear at present. One of us (TJS) has been particularly struck by the magnitude of the problems induced by AC-IOLs as seen in a referral glaucoma practice. To He underwent an ECCE which was complicated by vitreous loss. After a vitrectomy an AC-IOL was inserted. During the follow-up period of three years his visual acuity was never better than 20/300. His course was complicated by graft failure and cystoid macular oedema. Two repeat penetrating keratoplasty procedures were performed. At the last follow-up he had a visual acuity of counting fingers at 1 m, 2-3+ cystoid macular oedema, and 2+ corneal oedema, with graft rejection.
Case 3. A 63-year-old white male presented with no significant medical history and a best corrected visual acuity with a pinhole of 20/70 OS. He underwent an ECCE, which was complicated by vitreous loss and had primary implantation of an AC-IOL.
During a follow-up period of four years his course was complicated by chronic iritis, corneal oedema, vitritis, and a raised IOP. His best postoperative visual acuity was 20/200. He had 3-4+ inflammatory deposits on the IOL and had a peaked iris with atrophy secondary to haptic traction on the iris. Eleven months after surgery the inferior haptic was in the iris and the superior haptic was floating free. A cellophane maculopathy was present, and the IOL was subsequently removed. At his last follow-up the visual acuity was counting fingers at 60 cm. He had 4+ cystoid macular oedema, diffuse corneal oedema, and an unstable intraocular pressure.
Case 4. A 68-year-old white male presented with an initial visual acuity of 20/400. He underwent an ECCE complicated by vitreous loss and had an AC-IOL placed. His initial postoperative course was complicated by persistent iritis and vitreous haemorrhage. The superior footplates of the lens were noted to be in the iris at three months. At six months he was noted to have cystoid macular oedema and vitreous haemorrhage, and the IOL was subsequently removed. Twenty-five months after the operation he had a retinal detachment, which was successfully repaired. At his last follow-up 35 months after surgery he had a visual acuity of counting fingers at 60cm.
Case 5. A 71-year-old white male presented with an initial visual acuity of light perception OS. He underwent an ECCE OS complicated by vitreous loss and had an AC-IOL placed. His initial postoperative visual acuity was 20/70 with a pinhole. The eye was subsequently found to be hypotonous and inferior choroidals were present. Visual acuity decreased to counting fingers at 60 cm. Three months after operation he suffered a retinal detachment. Following repair the diagnosis of 'tight lens syndrome' and pupillary block was made, and the lens was removed. His subsequent course was complicated by rubeosis and progression to a total, inoperable retinal detachment. He had a retrobulbar block for pain control two years after surgery. At his last follow-up the visual acuity was no light perception OS.
Case 6. A 67-year-old white male presented with an initial visual acuity of 20/100. He underwent an ECCE complicated by vitreous loss, and an AC-IOL was inserted. Initial postoperative examination showed a 10% hyphaema. The pupil was slightly irregular, and his intraocular pressure was increased. The visual acuity was 20/200. His subsequent postoperative course was notable for multiple complications including malpositioning of the IOL, retinal detachment requiring surgical repair, chronic iritis, and chronic cystoid macular oedema. At his last follow-up visit he had a visual acuity of 20/200, 3+ guttae, and early bullous keratopathy. One of the IOL haptics was located in a peripheral iridotomy, and the IOL itself was covered with pigment. The role that placement of an AC-IOL after vitreous loss has on the incidence of complications and resultant visual outcome has not been clearly established. Jaffe' reported on 88 patients who received IOLs after vitreous loss. Visual acuity was better than 20/40 in about 80% of them. He concluded that IOL placement after vitreous loss was justified if the surgeon was experienced and that the incidence of complications was not high enough to contraindicate lens implantation. All but one of the IOLs used in this retrospective study were the Binkhorst iris clip lens, which has now become obsolete. Mazzocco4 reported a series of 38 patients who had IOLs placed after vitreous loss. Twentythree of these had the Choyce mark VIII placed; in these he noted an increased incidence of glaucoma. Nine of the 23 had glaucoma; all were medically controlled. He came to the same conclusion as did Jaffe. Nishi6 reported on 18 patients who had IOLs placed after vitreous loss. He used both anterior and posterior chamber lenses. The final visual acuity in this group ranged from 20/60 to 20/15, while in his control group it was 20/50 to 20/15. He also concluded that placement of an IOL after vitreous loss was not contraindicated.
Discussion
This series consists of 24 consecutive patients in whom an AC-IOL was placed after vitreous loss and for whom at least three months of follow-up is available. Eighteen of the patients (75%) achieved a visual acuity of 20/40 or better, which is in fairly close agreement with Jaffe's results' and similar to that found after vitreous loss alone.23 The remaining six patients, however, had multiple complications and a poor visual outcome (visual acuity 20/200 or worse). Some of these patients had complications directly attributable to the AC-IOL, which we believe may have contributed to their poor visual results.
Several of the complications known to occur after vitreous loss are also seen with the use of anterior chamber lenses. Glaucoma, uveitis, and comeal disease are all increased after vitreous loss. These complications are also seen with the use of an AC-IOL in uncomplicated surgery." Mazzocco's results4
indicate that there may be a combined effect of the two in the case of glaucoma, but no other study indicates that vitreous loss and an AC-IOL combined yield a significantly increased risk of these complications. Three of the patients reported on here (cases 1, 3, and 6) suffered from increased intraocular pressure. In case 1 this was caused by a pupillary block mechanism; the iris was noted to be prolapsing round the lens despite the presence of a peripheral iridectomy. Peripheral anterior synechiae were present. Case 3 had open-angle glaucoma thought to be secondary to chronic iritis, possibly from a malpositioned lens. Three patients (cases 3, 4, and 6) had uveitis. In all of these cases the lens was impinging on the iris. Three of the patients had evidence of corneal decompensation (cases 2, 3, and 6). Case 3 had diffuse corneal oedema after removal of the IOL. This may have been secondary to chronic uveitis or the trauma of lens removal.
An increased risk of retinal detachment follows vitreous loss.' 11-1" While there is no evidence that the use of an IOL increases this risk, the presence of an AC-IOL may make reattachment of the retina more difficult. Three patients had a retinal detachment (cases 4, 5, and 6). In case 4 this occurred several months after the removal of the IOL. In patient 5 the detachment was thought to be inoperable, and the visual acuity progressed to no light perception.
The incidence of cystoid macular oedema is increased after vitreous loss.' Whether an IOL alone increases the risk of this complication is not well established. Jaffe's results' seem to indicate an increased risk in those patients with an iris supported lens, but we are not aware of any study of anterior chamber lenses in association with this complication. Five of our patients had evidence of cystoid macular oedema (cases 1, 2, 3, 4, and 6).
We are concerned about the poor visual outcome in those patients who had complications following vitreous loss and placement of an AC-IOL. As in other series, however, the number of patients is very small. We do not think that a general statement concerning the safety of this practice would be valid. More than a million cataract extractions are performed every year in the United States alone'5; tens of thousands will suffer the complication of vitreous loss. We believe the complications associated with vitreous loss and AC-IOLs may be acting in concert to cause visually disabling results in some of these patients and that a large prospective study is warranted to delineate the effect an IOL has after vitreous loss. If the incidence of complications is proved to be increased, the surgeon and patient will be better able to weigh the benefits of an IOL after vitreous loss against the possible risk.
